Chimeric RNAs generated by intergenic splicing in normal and cancer cells

Genes Chromosomes and Cancer

Volumn 53, Issue 12, 2014, Pages 963-971

  Jividen, Kasey ^a   Li, Hui ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

CHROMOSOME ABERRATION; ENDOMETRIUM SARCOMA; ENDOMETRIUM TUMOR; FEMALE; GENE FUSION; GENETICS; HUMAN; MALE; METABOLISM; MUSCLE DEVELOPMENT; NEOPLASM; PROSTATE TUMOR; RHABDOMYOSARCOMA; RNA SPLICING; TRANS SPLICING;

CHROMOSOME ABERRATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FUSION; HUMANS; MALE; MUSCLE DEVELOPMENT; NEOPLASMS; PROSTATIC NEOPLASMS; RHABDOMYOSARCOMA; RNA; RNA SPLICING; SARCOMA, ENDOMETRIAL STROMAL; TRANS-SPLICING;

EID: 84907959171     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22207     Document Type: Review

References (77)

1. Agabian N. 1990. Trans splicing of nuclear pre-mRNAs. Cell 61:1157-1160.
2. Akiva P, Toporik A, Edelheit S, Peretz Y, Diber A, Shemesh R, Novik A, Sorek R. 2006. Transcription-mediated gene fusion in the human genome. Genome Res 16:30-36.
3. Birve A, Sengupta AK, Beuchle D, Larsson J, Kennison JA, Rasmuson-Lestander A, Muller J. 2001. Su(z)12, a novel Drosophila polycomb group gene that is conserved in vertebrates and plants. Development 128:3371-3379.
4. Bonen L. 1993. Trans-splicing of pre-mRNA in plants, animals, and protists. FASEB J 7:40-46.
5. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young RA, Jaenisch R. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441:349-353.
6. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. 2006. Genome-wide mapping of polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20:1123-1136.
7. Cao R, Zhang Y. 2004a. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15:57-67.
8. Cao R, Zhang Y. 2004b. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14:155-164.
9. Caudevilla C, Serra D, Miliar A, Codony C, Asins G, Bach M, Hegardt FG. 1998. Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver. Proc Natl Acad Sci USA 95:12185-12190.
10. Chiang S, Oliva E. 2011. Cytogenetic and molecular aberrations in endometrial stromal tumors. Hum Pathol 42:609-617.
11. Chinnaiyan AM, Palanisamy N. 2011. Chromosomal aberrations in solid tumors. Prog Mol Biol Transl Sci 95:55-94.
12. Cocquerelle C, Daubersies P, Majerus MA, Kerckaert JP, Bailleul B. 1992. Splicing with inverted order of exons occurs proximal to large introns. EMBO J 11:1095-1098.
13. Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, Lagarde J, Alioto T, Manzano C, Chrast J, Dike S, Wyss C, Henrichsen CN, Holroyd N, Dickson MC, Taylor R, Hance Z, Foissac S, Myers RM, Rogers J, Hubbard T, Harrow J, Guigo R, Gingeras TR, Antonarakis SE, Reymond A. 2007. Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res 17:746-759.
14. Dixon RJ, Eperon IC, Hall L, Samani NJ. 2005. A genome-wide survey demonstrates widespread non-linear mRNA in expressed sequences from multiple species. Nucleic Acids Res 33:5904-5913.
15. Dixon RJ, Eperon IC, Samani NJ. 2007. Complementary intron sequence motifs associated with human exon repetition: A role for intragenic, inter-transcript interactions in gene expression. Bioinformatics 23:150-155.
16. Dorn R, Reuter G, Loewendorf A. 2001. Transgene analysis proves mRNA trans-splicing at the complex mod(mdg4) locus in Drosophila. Proc Natl Acad Sci USA 98:9724-9729.
17. Downing JR, Khandekar A, Shurtleff SA, Head DR, Parham DM, Webber BL, Pappo AS, Hulshof MG, Conn WP, Shapiro DN. 1995. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol 146:626-634.
18. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL. 2001. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037.
19. Finta C, Zaphiropoulos PG. 2002. Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem 277:5882-5890.
20. Fischer SE, Butler MD, Pan Q, Ruvkun G. 2008. Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7. Nature 455:491-496.
21. Fitzgerald C, Sikora C, Lawson V, Dong K, Cheng M, Oko R, van der Hoorn FA. 2006. Mammalian transcription in support of hybrid mRNA and protein synthesis in testis and lung. J Biol Chem 281:38172-38180.
22. Flouriot G, Brand H, Seraphin B, Gannon F. 2002. Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene. J Biol Chem 277:26244-26251.
23. Frantz SA, Thiara AS, Lodwick D, Ng LL, Eperon IC, Samani NJ. 1999. Exon repetition in mRNA. Proc Natl Acad Sci USA 96:5400-5405.
24. Fredericks WJ, Galili N, Mukhopadhyay S, Rovera G, Bennicelli J, Barr FG, Rauscher FJ, 3rd. 1995. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol Cell Biol 15:1522-1535.
25. Gingeras TR. 2009. Implications of chimaeric non-co-linear transcripts. Nature 461:206-211.
26. Graf Finckenstein F, Shahbazian V, Davicioni E, Ren YX, Anderson MJ. 2008. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Oncogene 27:2004-2014.
27. Heim S, Mitelman F. 2008. Molecular screening for new fusion genes in cancer. Nat Genet 40:685-686.
28. Hernandez-Torres F, Rastrojo A, Aguado B. 2013. Intron retention and transcript chimerism conserved across mammals: Ly6g5b and Csnk2b-Ly6g5b as examples. BMC Genomics 14:199.
29. Horiuchi T, Giniger E, Aigaki T. 2003. Alternative trans-splicing of constant and variable exons of a Drosophila axon guidance gene, lola. Genes Dev 17:2496-2501.
30. Jehan Z, Vallinayagam S, Tiwari S, Pradhan S, Singh L, Suresh A, Reddy HM, Ahuja YR, Jesudasan RA. 2007. Novel noncoding RNA from human Y distal heterochromatic block (Yq12) generates testis-specific chimeric CDC2L2. Genome Res 17:433-440.
31. Kamikawa R, Inagaki Y, Tokoro M, Roger AJ, Hashimoto T. 2011. Split introns in the genome of Giardia intestinalis are excised by spliceosome-mediated trans-splicing. Curr Biol 21:311-315.
32. Kannan K, Wang L, Wang J, Ittmann MM, Li W, Yen L. 2011. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc Natl Acad Sci USA 108:9172-9177.
33. Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM, Meltzer PS. 1999. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 96:13264-13269.
34. Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den Berghe H, Dal Cin P, Fletcher JA, Sklar J. 2001. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98:6348-6353.
35. Krause M, Hirsh D. 1987. A trans-spliced leader sequence on actin mRNA in C. elegans. Cell 49:753-761.
36. Kumar-Sinha C, Kalyana-Sundaram S, Chinnaiyan AM. 2012. SLC45A3-ELK4 chimera in prostate cancer: Spotlight on cis-splicing. Cancer Discov 2:582-585.
37. Kurman RJ. 2002. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag.
38. Labrador M, Mongelard F, Plata-Rengifo P, Baxter EM, Corces VG, Gerasimova TI. 2001. Protein encoding by both DNA strands. Nature 409:1000.
39. Lai J, Lehman ML, Dinger ME, Hendy SC, Mercer TR, Seim I, Lawrence MG, Mattick JS, Clements JA, Nelson CC. 2010. A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells. RNA 16:1156-1166.
40. Lasda EL, Blumenthal T. 2011. Trans-splicing. Wiley Interdiscip Rev RNA 2:417-434.
41. Li H, Ma X, Wang J, Koontz J, Nucci M, Sklar J. 2007. Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival. Proc Natl Acad Sci USA 104:20001-20006.
42. Li H, Wang J, Mor G, Sklar J. 2008. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science 321:1357-1361.
43. Li H, Wang J, Ma X, Sklar J. 2009. Gene fusions and RNA trans-splicing in normal and neoplastic human cells. Cell Cycle 8:218-222.
44. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM. 2009a. Transcriptome sequencing to detect gene fusions in cancer. Nature 458:97-101.
45. Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, Khrebtukova I, Barrette TR, Grasso C, Yu J, Lonigro RJ, Schroth G, Kumar-Sinha C, Chinnaiyan AM. 2009b. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci USA 106:12353-12358.
46. Mitelman F. 2000. Recurrent chromosome aberrations in cancer. Mutat Res 462:247-253.
47. Mitelman F, Johansson B, Mertens F. 2004. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36:331-334.
48. Miltelman F, Johansson B, Mertens F. 2014. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Available at http://cgap.nci.nih.gov/chromosomes/mitelman. last accessed on October 5, 2014.
49. Mongelard F, Labrador M, Baxter EM, Gerasimova TI, Corces VG. 2002. Trans-splicing as a novel mechanism to explain interallelic complementation in Drosophila. Genetics 160:1481-1487.
50. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, Marra MA. 2010. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42:181-185.
51. Nacu S, Yuan W, Kan Z, Bhatt D, Rivers CS, Stinson J, Peters BA, Modrusan Z, Jung K, Seshagiri S, Wu TDS. 2011. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples. BMC Med Genomics 4:11.
52. Nigro JM, Cho KR, Fearon ER, Kern SE, Ruppert JM, Oliner JD, Kinzler KW, Vogelstein B. 1991. Scrambled exons. Cell 64:607-613.
53. Nowacki M, Vijayan V, Zhou Y, Schotanus K, Doak TG, Landweber LF. 2008. RNA-mediated epigenetic programming of a genome-rearrangement pathway. Nature 451:153-158.
54. Ntziachristos P, Tsirigos A, Van Vlierberghe P, Nedjic J, Trimarchi T, Flaherty MS, Ferres-Marco D, da Ros V, Tang Z, Siegle J, Asp P, Hadler M, Rigo I, De Keersmaecker K, Patel J, Huynh T, Utro F, Poglio S, Samon JB, Paietta E, Racevskis J, Rowe JM, Rabadan R, Levine RL, Brown S, Pflumio F, Dominguez M, Ferrando A, Aifantis I. 2012. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med 18:298-301.
55. Osborne CS, Chakalova L, Mitchell JA, Horton A, Wood AL, Bolland DJ, Corcoran AE, Fraser P. 2007. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol 5:e192.
56. Panagopoulos I. 2010. Absence of the JAZF1/SUZ12 chimeric transcript in the immortalized non-neoplastic endometrial stromal cell line T HESCs. Oncol Lett 1:947-950.
57. Parra G, Reymond A, Dabbouseh N, Dermitzakis ET, Castelo R, Thomson TM, Antonarakis SE, Guigo R. 2006. Tandem chimerism as a means to increase protein complexity in the human genome. Genome Res 16:37-44.
58. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
59. Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA. 2009. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res 69:2734-2738.
60. Rowley JD. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293.
61. Rowley JD. 1999. The role of chromosome translocations in leukemogenesis. Semin Hematol 36:59-72.
62. Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA, Shapiro GI, Costa DB, Ou SH, Butaney M, Salgia R, Maki RG, Varella-Garcia M, Doebele RC, Bang YJ, Kulig K, Selaru P, Tang Y, Wilner KD, Kwak EL, Clark JW, Iafrate AJ, Camidge DR. 2011. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 12:1004-1012.
63. Siepel A, Diekhans M, Brejova B, Langton L, Stevens M, Comstock CL, Davis C, Ewing B, Oommen S, Lau C, Yu HC, Li J, Roe BA, Green P, Gerhard DS, Temple G, Haussler D, Brent MR. 2007. Targeted discovery of novel human exons by comparative genomics. Genome Res 17:1763-1773.
64. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG. 2002. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the children's oncology group. J Clin Oncol 20:2672-2679.
65. Storici F, Bebenek K, Kunkel TA, Gordenin DA, Resnick MA. 2007. RNA-templated DNA repair. Nature 447:338-341.
66. Sutton RE, Boothroyd JC. 1986. Evidence for trans splicing in trypanosomes. Cell 47:527-535.
67. Takahara T, Kanazu SI, Yanagisawa S, Akanuma H. 2000. Heterogeneous Sp1 mRNAs in human HepG2 cells include a product of homotypic trans-splicing. J Biol Chem 275:38067-38072.
68. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF, Jr., Hoover R, Hayes RB, Hunter DJ, Chanock SJ. 2008. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40:310-315.
69. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-629.
70. Velusamy T, Palanisamy N, Kalyana-Sundaram S, Sahasrabuddhe AA, Maher CA, Robinson DR, Bahler DW, Cornell TT, Wilson TE, Lim MS, Chinnaiyan AM, Elenitoba-Johnson KS. 2013. Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 110:3035-3040.
71. Wang K, Ubriaco G, Sutherland LC. 2007. RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours. BMC Genomics 8:348.
72. Wu CS, Yu CY, Chuang CY, Hsiao M, Kao CF, Kuo HC, Chuang TJ. 2014. Integrative transcriptome sequencing identifies trans-splicing events with important roles in human embryonic stem cell pluripotency. Genome Res 24:25-36.
73. Yuan H, Qin F, Movassagh M, Park H, Golden W, Xie Z, Zhang P, Sklar J, Li H. 2013. A chimeric RNA characteristic of rhabdomyosarcoma in normal myogenesis process. Cancer Discov 3:1394-1403.
74. Zaphiropoulos PG. 2012. Trans-splicing in higher eukaryotes: Implications for cancer development? Front Genet 2:92.
75. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G, Ardlie K, Bostrom KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling TM, Freathy RM, Gianniny L, Grallert H, Grarup N, Groves CJ, Guiducci C, Hansen T, Herder C, Hitman GA, Hughes TE, Isomaa B, Jackson AU, Jorgensen T, Kong A, Kubalanza K, Kuruvilla FG, Kuusisto J, Langenberg C, Lango H, Lauritzen T, Li Y, Lindgren CM, Lyssenko V, Marvelle AF, Meisinger C, Midthjell K, Mohlke KL, Morken MA, Morris AD, Narisu N, Nilsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C, Prokopenko I, Qi L, Qin L, Rayner NW, Rees M, Roix JJ, Sandbaek A, Shields B, Sjogren M, Steinthorsdottir V, Stringham HM, Swift AJ, Thorleifsson G, Thorsteinsdottir U, Timpson NJ, Tuomi T, Tuomilehto J, Walker M, Watanabe RM, Weedon MN, Willer CJ, Illig T, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT, Collins FS, Groop L, McCarthy MI, Boehnke M, Altshuler D. 2008. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638-645.
76. Zhang C, Xie Y, Martignetti JA, Yeo TT, Massa SM, Longo FM. 2003. A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs. DNA Cell Biol 22:303-315.
77. Zhang Y, Gong M, Yuan H, Park HG, Frierson HF, Li H. 2012. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov 2:598-607.